Results 211 to 220 of about 2,517,861 (360)

Anti-NMDA-Receptor GluN1 Antibody Serostatus Is Robust in Acute Severe Stroke. [PDF]

Diagnostics (Basel)
Sperber PS, Hotter B, Endres M, Prüss H, Meisel A.   +4 more
europepmc   +1 more source

Preclinical models for evaluating psychedelics in the treatment of major depressive disorder

British Journal of Pharmacology, EarlyView.
Psychedelic drugs have seen a resurgence in interest as a next generation of psychiatric medicines with potential as rapid‐acting antidepressants (RAADs). Despite promising early clinical trials, the mechanisms which underlie the effects of psychedelics are poorly understood.
Laith Alexander, Dasha Anderson, Luke Baxter, Matthew Claydon, James Rucker, Emma S. J. Robinson   +5 more
wiley   +1 more source

NMDA receptors trigger taurine release in the ischemic brain

, 1992
M. Puka, Ryszard Pluta, Elżbieta Salińska, Jan Albrecht, Jerzy W. Łazarewicz   +4 more
openalex   +1 more source

Psychedelics, entactogens and psychoplastogens for depression and related disorders

British Journal of Pharmacology, EarlyView.
Currently, the most actively investigated rapidly acting antidepressants, anxiolytics and/or anti PTSD agents, include psychedelics e.g. psilocybin, LSD, N,N‐dimethyltryptamine, ayahuasca; non‐hallucinogenic entactogens, e.g. MDMA; psychoplastogens which rapidly promote neuroplasticity, e.g.
Daniel Hoyer
wiley   +1 more source

Trans-synaptic molecular context of NMDA receptor nanodomains. [PDF]

Nat Commun
Anderson MC, Dharmasri PA, Damenti M, Metzbower SR, Laghaei R, Blanpied TA, Levy AD.   +6 more
europepmc   +1 more source

Loss of NMDA receptors in dopamine neurons leads to the development of affective disorder-like symptoms in mice [PDF]

, 2016
Kamila Jastrzębska, Magdalena Walczak, Przemysław Eligiusz Cieślak, Łukasz Szumiec, Mateusz Turbasa, David Engblom, Tomasz Błasiak, Jan Rodriguez Parkitna   +7 more
openalex   +1 more source

Psychedelics as pharmacotherapeutics for substance use disorders: A scoping review on clinical trials and perspectives on underlying neurobiology

British Journal of Pharmacology, EarlyView.
Theorized mechanism of dopamine homeostasis restoration in the nucleus accumbens core induced by a psychedelic intervention. Abstract Psychedelics have garnered great attention in recent years as treatments for major depressive disorder (MDD) and treatment‐resistant depression because of their ability to alter consciousness and afflicted cognitive ...
Lucas Wittenkeller, Gary Gudelsky, T. John Winhusen, Davide Amato   +3 more
wiley   +1 more source

Visualization of Structural Changes Accompanying Activation of N-Methyl-d-aspartate (NMDA) Receptors Using Fast-scan Atomic Force Microscopy Imaging [PDF]

, 2012
Yuki Suzuki, Tom A. Goetze, David Stroebel, Dilshan Balasuriya, Shige H. Yoshimura, Robert M. Henderson, Pierre Paoletti, Kunio Takeyasu, J. Michael Edwardson   +8 more
openalex   +1 more source

Mice with Reduced NMDA Receptor Expression Display Behaviors Related to Schizophrenia

Cell, 1999
A. R. Mohn, R. Gainetdinov, M. Caron, B. Koller   +3 more
semanticscholar   +1 more source

Novel approaches for drug development against chronic primary pain: A systematic review

British Journal of Pharmacology, EarlyView.
Abstract Chronic primary pain (CPP) persisting for more than 3 months, associated with significant emotional distress without any known underlying cause, is an unmet medical need. Traditional or adjuvant analgesics do not provide satisfactory pain relief for a great proportion of these patients.
Valéria Tékus, Éva Borbély, Andreas Goebel, Ralf Baron, Zsófia Hajna, Zsuzsanna Helyes   +5 more
wiley   +1 more source